Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

DECONSOLIDATION OF ORANIM PHARMACY (Tables)

v3.24.2.u1
DECONSOLIDATION OF ORANIM PHARMACY (Tables)
6 Months Ended
Jun. 30, 2024
Discontinued Operations And Deconsolidation [Abstract]  
Disclosure of consolidated statement of financial position of discontinued operations [Table Text Block]
   
April 15,
2024
   
December 31,
2023
 
ASSETS
           
             
Current assets:
           
   Cash and cash equivalents
 
$
346
   
$
308
 
   Trade receivables
   
1,324
     
1,289
 
   Other accounts receivable
   
758
      761  
   Inventories
   
837
     
725
 
                 
     
3,265
     
3,083
 
Non-current assets:
               
   Property, plant and equipment, net
   
783
     
802
 
   Right-of-use assets, net
   
533
     
565
 
   Intangible assets, net
   
1,414
     
1,575
 
   Goodwill
   
3,499
     
3,455
 
                 
     
6,229
     
6,397
 
                 
   Total Assets
 
$
9,494
   
$
9,480
 
 
   
April 15,
2024
   
December 31,
2023
 
LIABILITIES
           
             
Current liabilities:
           
Trade payables
 
$
1,597
   
$
1,477
 
Other accounts payable and accrued expenses
   
176
      230  
Purchase consideration payable
   
2,172
     
2,097
 
Put option liability
   
1,973
     
2,697
 
Current maturities of operating lease liabilities
   
155
     
152
 
                 
     
6,073
     
6,653
 
Non-current liabilities:
               
Lease liabilities
   
372
     
406
 
Deferred tax liability, net
   
326
     
364
 
                 
     
698
     
770
 
                 
   Total liabilities
 
$
6,771
   
$
7,423
 
    Non controlling interest   $ (41 )   $ 219